A carregar...
Noncytotoxic Pyrrolobenzodiazepine–Ciprofloxacin Conjugate with Activity against Mycobacterium tuberculosis
[Image: see text] The development of new antitubercular agents for the treatment of infections caused by multidrug-resistant (MDR) Mycobacterium tuberculosis is an urgent priority. Pyrrolobenzodiazepines (PBDs) are a promising class of antibacterial agents that were initially discovered and isolated...
Na minha lista:
| Publicado no: | ACS Omega |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Chemical Society
2019
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6921268/ https://ncbi.nlm.nih.gov/pubmed/31867477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsomega.9b00834 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|